lifestyle.small-bizsense.com

Author: CVRx, Inc.

CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

April 20, 2026
CVRx Reports Preliminary First Quarter 2026 Financial Results

April 13, 2026
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting

March 2, 2026
CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population

February 25, 2026
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

February 12, 2026
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026

January 29, 2026